Connect with us

News

Mars travelers can use ‘Star Trek’ Tricorder-like features using smartphone biotech: study

Published

on

Plans to take humans to the Moon and Mars come with numerous challenges, and the health of space travelers is no exception. One of the ways any ill-effects can be prevented or mitigated is by detecting relevant changes in the body and the body’s surroundings, something that biosensor technology is specifically designed to address on Earth. However, the small size and weight requirements for tech used in the limited habitats of astronauts has impeded its development to date.

A recent study of existing smartphone-based biosensors by scientists from Queen’s University Belfast (QUB) in the UK identified several candidates under current use or development that could be also used in a space or Martian environment. When combined, the technology could provide functionality reminiscent of the “Tricorder” devices used for medical assessments in the Star Trek television and movie franchises, providing on-site information about the health of human space travelers and biological risks present in their habitats.

Biosensors focus on studying biomarkers, i.e., the body’s response to environmental conditions. For example, changes in blood composition, elevations of certain molecules in urine, heart rate increases or decreases, and so forth, are all considered biomarkers. Health and fitness apps tracking general health biomarkers have become common in the marketplace with brands like FitBit leading the charge for overall wellness sensing by tracking sleep patterns, heart rate, and activity levels using wearable biosensors. Astronauts and other future space travelers could likely use this kind of tech for basic health monitoring, but there are other challenges that need to be addressed in a compact way.

The projected human health needs during spaceflight have been detailed by NASA on its Human Research Program website, more specifically so in its web-based Human Research Roadmap (HRR) where the agency has its scientific data published for public review. Several hazards of human spaceflight are identified, such as environmental and mental health concerns, and the QUB scientists used that information to organize their study. Their research produced a 20-page document reviewing the specific inner workings of the relevant devices found in their searches, complete with tables summarizing each device’s methods and suitability for use in space missions. Here are some of the highlights.

A chart showing the classification of scientific articles about relevant smartphone-based biosensors used in the Queen’s University Belfast study. | Credit: Biosensors/Queen’s University Belfast

Risks in the Spacecraft Environment

During spaceflight, the environment is a closed system that has a two-fold effect: One, the immune system has been shown to decrease its functionality in long-duration missions, specifically by lowering white blood cell counts, and two, the weightless and non-competitive environment make it easier for microbes to transfer between humans and their growth rates increase. In one space shuttle era study, the number of microbial cells in the vehicle able to reproduce increased by 300% within 12 days of being in orbit. Also, certain herpes viruses, such as those responsible for chickenpox and mononucleosis, have been reactivated under microgravity, although the astronauts typically didn’t show symptoms despite the presence of active viral shedding (the virus had surfaced and was able to spread).

Frequent monitoring of the spacecraft environment and the crew’s biomarkers is the best way to mitigate these challenges, and NASA is addressing these issues to an extent with traditional instruments and equipment to collect data, although often times the data cannot be processed until the experiments are returned to Earth. An attempt has also been made to rapidly quantify microorganisms aboard the International Space Station (ISS) via a handheld device called the Lab-on-a-Chip Application Development-Portable Test System (LOCAD-PTS). However, this device cannot distinguish between microorganism species yet, meaning it can’t tell the difference between pathogens and harmless species. The QUB study found several existing smartphone-based technologies generally developed for use in remote medical care facilities that could achieve better identification results.

NASA astronaut Karen Nyberg uses a fundoscope to image her eye while in orbit to study Visual Impairment Intracranial Pressure (VIIP) Syndrome. Smaller 3D printed retinal imaging adaptors for smartphones are being developed to perform the testing done by large devices similar to the instrument used here. | Credit: NASA

One of the devices described was a spectrometer (used to identify substances based on the light frequency emitted) which used the smartphone’s flashlight and camera to generate data that was at least as accurate as traditional instruments. Another was able to identify concentrations of an artificial growth hormone injected into cows called recominant bovine somatrotropin (rBST) in test samples, and other systems were able to accurately detect cyphilis and HIV as well as the zika, chikungunya, and dengue viruses. All of the devices used smartphone attachments, some of them with 3D-printed parts. Of course, the types of pathogens detected are not likely to be common in a closed space habitat, but the technology driving them could be modified to meet specific detection needs.

The Stress of Spaceflight

A group of people crammed together in a small space for long periods of time will be impacted by the situation despite any amount of careful selection or training due to the isolation and confinement. Declines in mood, cognition, morale, or interpersonal interaction can impact team functioning or transition into a sleep disorder. On Earth, these stress responses may seem common, or perhaps an expected part of being human, but missions in deep space and on Mars will be demanding and need fully alert, well-communicating teams to succeed. NASA already uses devices to monitor these risks while also addressing the stress factor by managing habitat lighting, crew movement and sleep amounts, and recommending astronauts keep journals to vent as needed. However, an all-encompassing tool may be needed for longer-duration space travels.

Advertisement
-

As recognized by the QUB study, several “mindfulness” and self-help apps already exist in the market and could be utilized to address the stress factor in future astronauts when combined with general health monitors. For example, the popular FitBit app and similar products collect data on sleep patterns, activity levels, and heart rates which could potentially be linked to other mental health apps that could recommend self-help programs using algorithms. The more recent “BeWell” app monitors physical activity, sleep patterns, and social interactions to analyze stress levels and recommend self-help treatments. Other apps use voice patterns and general phone communication data to assess stress levels such as “StressSense” and “MoodSense”.

A Tricorder-like setup is imagined by scientists at Queens University Belfast, utilizing the functionalities of existing smartphone-based biosensors. | Credit: Biosensors/Queens University Belfast

Advances in smartphone technology such as high resolution cameras, microphones, fast processing speed, wireless connectivity, and the ability to attach external devices provide tools that can be used for an expanding number of “portable lab” type functionalities. Unfortunately, though, despite the possibilities that these biosensors could mean for human spaceflight needs, there are notable limitations that would need to be overcome in some of the devices. In particular, any device utilizing antibodies or enzymes in its testing would risk the stability of its instruments thanks to radiation from galactic cosmic rays and solar particle events. Biosensor electronics might also be damaged by these things as well. Development of new types of shielding may be necessary to ensure their functionality outside of Earth and Earth orbit or, alternatively, synthetic biology could also be a source of testing elements genetically engineered to withstand the space and Martian environments.

The interest in smartphone-based solutions for space travelers has been garnering more attention over the years as tech-centric societies have moved in the “app” direction overall. NASA itself has hosted a “Space Apps Challenge” for the last 8 years, drawing thousands of participants to submit programs that interpret and visualize data for greater understanding of designated space and science topics. Some of the challenges could be directly relevant to the biosensor field. For example, in the 2018 event, contestants are asked to develop a sensor to be used by humans on Mars to observe and measure variables in their environments; in 2017, contestants created visualizations of potential radiation exposure during polar or near-polar flight.

While the QUB study implied that the combination of existing biosensor technology could be equivalent to a Tricorder, the direct development of such a device has been the subject of its own specific challenge. In 2012, the Qualcomm Tricorder XPRIZE competition was launched, asking competitors to develop a user-friendly device that could accurately diagnose 13 health conditions and capture 5 real-time health vital signs. The winner of the prize awarded in 2017 was Pennsylvania-based family team called Final Frontier Medical Devices, now Basil Leaf Technologies, for their DxtER device. According to their website, the sensors inside DxtER can be used independently, one of which is in a Phase 1 Clinical Trial. The second place winner of the competition used a smartphone app to connect its health testing modules and generate a diagnosis from the data acquired from the user.

The march continues to develop the technology humans will need to safely explore regions beyond Earth orbit. Space is hard, but it was hard before we went there the first time, and it was hard before we put humans on the moon. There may be plenty of challenges to overcome, but as the Queen’s University Belfast study demonstrates, we may already be solving them. It’s just a matter of realizing it and expanding on it.

Accidental computer geek, fascinated by most history and the multiplanetary future on its way. Quite keen on the democratization of space. | It's pronounced day-sha, but I answer to almost any variation thereof.

Advertisement
Comments

News

Tesla makes €3 billion Cybercab bet at Giga Berlin

Published

on

Credit: Tesla

It is no secret Tesla is prioritizing Cybercab production as it plans to launch a fleet of fully autonomous vehicles without steering wheels or pedals across the world. Today, it made a €3 billion bet to do so in Europe.

Tesla announced on November 16, that it will invest €3 billion (approximately $3.3 billion) to expand its Gigafactory in Grünheide near Berlin, its only vehicle manufacturing site in Europe.

The investment will fund a major new production building—roughly twice the size of the existing main hall—and supporting infrastructure, including an additional wastewater treatment plant. The new facility is designed to produce up to one million Cybercabs annually once fully scaled, alongside continued Model Y output.

Advertisement
-

Tesla plans to file the building permit application before the end of 2026, according to Tagesspiegel, drawing on a broader expansion application submitted in 2023 that targets one million vehicles per year overall. Construction is scheduled to begin in the first half of 2027, with Cybercab production starting in 2029.

The company is already recruiting several hundred workers for construction and production planning. The site currently employs about 12,600 people after recent hiring of roughly 2,000, and it is ramping Model Y production toward 7,500 vehicles per week (around 375,000 annually).

This vehicle expansion comes just days after plant manager André Thierig indicated at the Automobilwoche Congress on November 11 that full battery cell production at Grünheide is on track for mid-2027.

The factory already produces electrodes, which are currently shipped to Texas for cell assembly and returned; the goal is to complete 4680-format cells on site using Tesla’s dry-electrode process, targeting up to 18 GWh annually.

The cumulative investment in the cell operation approaches €1 billion and is expected to create more than 1,500 jobs. Once operational, Giga Berlin would become the first plant in Europe to produce everything from battery cells to finished vehicles under one roof, raising the European content of its Model Ys to roughly 90 percent.

For Tesla’s German operations, the twin moves deepen vertical integration and reduce dependence on transatlantic and Chinese supply chains.

Advertisement
-

They also contrast sharply with the broader German automotive industry, which faces high costs, weak demand, and job cuts; Brandenburg officials have welcomed the investment as a significant economic boost that creates hundreds of new positions and strengthens the region as a manufacturing hub.

Tesla’s expansion advances its strategic pivot toward autonomy and robotaxis. The Cybercab is intended to become a high-volume product; adding major European capacity diversifies production beyond the United States and supports Elon Musk’s vision of autonomous vehicles comprising the majority of Tesla’s future output.

Combined with localized 4680 cell production, the plans position Giga Berlin as a more self-sufficient, technologically advanced European base, enhancing competitiveness as regulatory and market conditions favor higher local content.

Continue Reading

Elon Musk

Elon Musk is already planning a bigger Starship, and the Moon may be why

Elon Musk revealed Starship V4 specs that could reshape how fast SpaceX reaches the Moon.

Published

on

By

A day after SpaceX caught a Starship upper stage for the first time, Elon Musk laid out how much bigger the next version will get. “Starship V4 will be ~70m long, which is roughly a 40% length increase and allows >60% more propellant load,” Musk wrote on X Sunday evening. “Engine count will be raised to 9, with 3 more Raptor-Vacuum engines added, and these will be higher thrust V4 engines.”

The current V3 ship that flew on Flight 15 stands about 52 meters tall with six Raptors, three built for sea level and three for vacuum. V4 stretches the ship and doubles its vacuum engines. Musk first said in August 2025 that V4 would add three engines to “a significantly longer ship” and fly in 2027. Sunday’s post is the most specific look at the ship so far.

The payload jump is the headline for the rest of the industry. SpaceX said in its IPO prospectus that V3 is expected to carry about 100 metric tons to orbit, while future generations could reach 200 metric tons, potentially as soon as V4. For comparison, a reusable Falcon 9 carries roughly 17 metric tons to low Earth orbit.

The bigger impact may be on the Moon. Every Starship lunar mission depends on filling a propellant depot in orbit with a string of tanker flights before the lander departs. A NASA safety panel member put that number at around 22 flights last month, while Musk countered that it would be “more like 6 to 8,” as Teslarati reported. Much of that gap comes down to which ship is doing the hauling. Musk has said a V4 tanker could deliver more than 200 tons of propellant per flight, which by his math brings a lunar refill down to five or six launches.

Fewer tankers per landing means more landings per year. SpaceX already advertises cargo flights to the lunar surface starting no earlier than 2028 at $100 million per metric ton, with a Starship lander able to put up to 100 tons on the surface. In February, Musk said SpaceX had shifted its focus to “a self-growing city on the Moon,” which he believes could be done in under 10 years, as Teslarati covered. NASA’s Artemis IV landing is targeted for 2028, and the White House has called for work on a permanent lunar outpost to begin by 2030.

Advertisement
-

None of that works without ships that fly more than once, which is where Ship 42 comes in. Musk spent part of Sunday at the pad inspecting the vehicle caught on Saturday. “I was going over the whole Starship heat shield earlier today. Overall, it looks great. The engines look great too. Ship 42 could probably be reflown with a few weeks of refurbishment,” he wrote. He added that “many small fixes are needed to achieve immediate reusability (like an airplane).”

SpaceX has never reflown a ship. Its two booster reflights each came months apart, so a Ship 42 return to flight within weeks would be a first for the program. Flight 15 already showed the ship can survive a full orbital mission and come home to the tower, as Teslarati reported Saturday.

Continue Reading

Elon Musk

MKBHD just ordered the Tesla Cybercab with his hair on the line

MKBHD ordered a Tesla Cybercab, two years after betting his hair Tesla couldn’t sell one.

Published

on

By

Rendering of Marques Brownlee (MKBHD) stands in the parking lot of Kearny Point (his New Jersey studio headquarters), looking at a gold Tesla Cybercab.

Marques Brownlee spent two years betting his hair that Tesla would never sell a Cybercab to regular buyers for under $30,000 before 2027. On Friday, he posted on X that he had been invited to buy one. “Alright chat I’m in,” the YouTuber known as MKBHD wrote, before sharing a screenshot that read “Your Cybercab Order is Confirmed.”

The bet dates back to Tesla’s We, Robot event in October 2024, when Elon Musk unveiled the two seat Cybercab and said customers would be able to buy one for less than $30,000, with production starting “before 2027.” Days later, in a video titled “The Tesla Robotaxi is Confusing,” Brownlee called the timeline “notorious Elon stuff” and said that if Tesla pulled it off, he would “shave my head on camera because I’m that confident.”

Musk accepted the challenge in February, when the first production Cybercab rolled off the Giga Texas line. Asked on X whether Tesla would sell a Cybercab to a customer for $30,000 or less before 2027, he answered “Yes,” and added “Gonna happen,” as Teslarati reported at the time. Brownlee narrowed the terms in a September video, saying the bet was that a “golden robotaxi with two seats and no driver and no steering wheel and no pedals” would not ship “to regular people like you and me for $30,000 before the end of this year.”

Tesla’s invite only order page now lists the Cybercab at $29,990, ten dollars under that line, with estimated deliveries in December. Buyers put down a $1,000 non-refundable deposit, must take delivery in Austin, Dallas, Fort Worth, Houston or San Antonio, and are limited to one vehicle each. A $299 per month Autonomy Subscription is required for the car to operate.

Brownlee is not conceding. “My hair is safe for several reasons,” he wrote, pointing out that no Cybercabs have been delivered and that orders are invite only rather than publicly available. He also noted that the car is limited to personal use inside Tesla’s existing Robotaxi geofences, calling it “a paperweight if I take this thing home,” though he acknowledged that point was never part of the bet. He then asked Grok to set a timer for 48 days, which lands on December 31.

Advertisement
-

Musk responded directly. Replying to Brownlee’s breakdown of the order page, he said the Cybercab “will be available nationwide, as we receive regulatory approval,” and agreed that “the monthly fee is too high”. He said it should match the cost of FSD and connectivity on Tesla’s other models, “more like ~$115/month.” In a separate reply about Brownlee’s hair, Musk wrote, “He’s a chicken.”

Where Brownlee’s car would go is unclear. He lives in New Jersey, far outside any Robotaxi service area, and Tesla’s agreements restrict where owners can operate the vehicle and how they can resell it, as Teslarati detailed.

Continue Reading